ABOUT US About Celltrion Notice Media Center BUSINESS Business Areas R&D Production Distribution PRODUCTS Products Pipeline ESG Environmental Social Governance ESG Archive IR Financial Information Stock Summary Public Disclosures IR Archive CAREERS Our Values How to Apply Jobs KOR ENG Choose Other Countries Europe Asia Pacific North America Latin America close Denmark Finland (FI) Finland (SV) France Germany Hungary Ireland Italy Netherlands Norway (NO) Norway (SV) Poland Portugal Spain Sweden Switzerland Türkiye United Kingdom Korea (HQ) Korea (EN) Japan Australia New Zealand Vietnam Canada (EN) Canada (FR) USA Brazil Chile Colombia Mexico Peru
ALL Discovery Spotlight ESG People All Title Content delete search Spotlight Celltrion and KBIS Launch the First Korea Japan Public-Private Open Innovation Initiative: 2026 KBIC Celltrion Global Scale-Up Program 2026.09.21 Discovery Precision Cancer Cell Targeting with ADCs and Celltrion’s Next-Generation Oncology Therapies 2026.09.01 Discovery Understanding the Symptoms and Causes of Psoriasis: Key Types and Treatments 2026.08.27 Discovery The Final Stage of Biopharmaceutical Manufacturing: Inside Celltrion’s Drug Product (DP) Process 2026.07.29 Discovery The Unsung Guardian of Patient Safety: The World of Biopharmaceutical Quality Control (QC) 2026.07.21 Discovery Chronic Inflammation That Attacks Your Body: A Guide to Rheumatoid Arthritis, from Symptoms to Treatment 2026.07.21 People Celltrion Acquires French Healthcare Company Gifrer to Strengthen Its Position in Europe 2026.07.03 ESG Bringing More Balance to Work and Life: Celltrion’s “Camo Class” 2026.05.29 Discovery Celltrion’s Biopharmaceutical and Antibody Therapeutics Development Expertise: Our Distinct Strengths 2026.05.29 First 1 2 3 Last
